Figure 9.
Sustained release of VEGF promotes COL I (A) and CD 31 (B) expression in bone-surrounding scaffolds 6 and 12 weeks after implantation (n = 3) [44].
Sustained release of VEGF promotes COL I (A) and CD 31 (B) expression in bone-surrounding scaffolds 6 and 12 weeks after implantation (n = 3) [44].